These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22449949)

  • 1. The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation.
    Le Henaff C; Gimenez A; Haÿ E; Marty C; Marie P; Jacquot J
    Am J Pathol; 2012 May; 180(5):2068-75. PubMed ID: 22449949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice.
    Haston CK; Li W; Li A; Lafleur M; Henderson JE
    Am J Respir Crit Care Med; 2008 Feb; 177(3):309-15. PubMed ID: 18006890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopenia in Cftr-deltaF508 mice.
    Paradis J; Wilke M; Haston CK
    J Cyst Fibros; 2010 Jul; 9(4):239-45. PubMed ID: 20570219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe osteopenia in CFTR-null mice.
    Dif F; Marty C; Baudoin C; de Vernejoul MC; Levi G
    Bone; 2004 Sep; 35(3):595-603. PubMed ID: 15336594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation.
    Blanchard E; Marie S; Riffault L; Bonora M; Tabary O; Clement A; Jacquot J
    Biochem Biophys Res Commun; 2011 Aug; 411(3):471-6. PubMed ID: 21723850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deletion of keratin 8 corrects the altered bone formation and osteopenia in a mouse model of cystic fibrosis.
    Le Henaff C; Faria Da Cunha M; Hatton A; Tondelier D; Marty C; Collet C; Zarka M; Geoffroy V; Zatloukal K; Laplantine E; Edelman A; Sermet-Gaudelus I; Marie PJ
    Hum Mol Genet; 2016 Apr; 25(7):1281-93. PubMed ID: 26769674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis.
    Le Henaff C; Haÿ E; Velard F; Marty C; Tabary O; Marie PJ; Jacquot JP
    Am J Pathol; 2014 Apr; 184(4):1132-1141. PubMed ID: 24529904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the cystic fibrosis mutation F508del-CFTR on renal cyst formation and growth.
    Li H; Yang W; Mendes F; Amaral MD; Sheppard DN
    Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1176-86. PubMed ID: 22874761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator.
    Jourdain ML; Sergheraert J; Braux J; Guillaume C; Gangloff SC; Hubert D; Velard F; Jacquot J
    Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166010. PubMed ID: 33188942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.
    Ramalho AS; Beck S; Meyer M; Penque D; Cutting GR; Amaral MD
    Am J Respir Cell Mol Biol; 2002 Nov; 27(5):619-27. PubMed ID: 12397022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of intestinal and lung alkaline sphingomyelinase and neutral ceramidase in cystic fibrosis f508del transgenic mice.
    Ohlsson L; Hjelte L; Hühn M; Scholte BJ; Wilke M; Flodström-Tullberg M; Nilsson A
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):547-54. PubMed ID: 18955860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.
    Roxo-Rosa M; Xu Z; Schmidt A; Neto M; Cai Z; Soares CM; Sheppard DN; Amaral MD
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17891-6. PubMed ID: 17098864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect.
    Robert R; Carlile GW; Pavel C; Liu N; Anjos SM; Liao J; Luo Y; Zhang D; Thomas DY; Hanrahan JW
    Mol Pharmacol; 2008 Feb; 73(2):478-89. PubMed ID: 17975008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
    Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
    Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis transmembrane conductance regulator in human muscle: Dysfunction causes abnormal metabolic recovery in exercise.
    Lamhonwah AM; Bear CE; Huan LJ; Kim Chiaw P; Ackerley CA; Tein I
    Ann Neurol; 2010 Jun; 67(6):802-8. PubMed ID: 20517942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population screening of F508del (DeltaF508), the most frequent mutation in the CFTR gene associated with cystic fibrosis in Argentina.
    Roqué M; Godoy CP; Castellanos M; Pusiol E; Mayorga LS
    Hum Mutat; 2001 Aug; 18(2):167. PubMed ID: 11462248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation.
    Pasyk S; Molinski S; Ahmadi S; Ramjeesingh M; Huan LJ; Chin S; Du K; Yeger H; Taylor P; Moran MF; Bear CE
    Proteomics; 2015 Jan; 15(2-3):447-61. PubMed ID: 25330774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Phe508 in the first nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone.
    Scott-Ward TS; Amaral MD
    FEBS J; 2009 Dec; 276(23):7097-109. PubMed ID: 19878303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chemical corrector modifies the channel function of F508del-CFTR.
    Kim Chiaw P; Wellhauser L; Huan LJ; Ramjeesingh M; Bear CE
    Mol Pharmacol; 2010 Sep; 78(3):411-8. PubMed ID: 20501743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small intestinal glucose absorption in cystic fibrosis: a study in human and transgenic DeltaF508 cystic fibrosis mouse tissues.
    Hardcastle J; Harwood MD; Taylor CJ
    J Pharm Pharmacol; 2004 Mar; 56(3):329-38. PubMed ID: 15025858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.